Design paper: A phase II study of Bevacizumab and Erlotinib in patients with non-Squamous non-small cell lung cancer that is refractory or relapsed after 1-2 previous Treatment (BEST)

<p>Abstract</p> <p>Background</p> <p>Combination of erlotinib and bevacizumab is a promising regimen in advanced non-squamous non-small-cell lung cancer (NSCLC). We are conducting a single arm phase II trial which aims to evaluate the efficacy and safety of this regime...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Kim Young H, Hazama Megumi, Niimi Miyuki, Sakamori Yuichi, Tanaka Shiro, Yanagihara Kazuhiro
Formato: Artigo
Idioma:Inglês
Publicado em: BMC 2011-05-01
Colecção:Trials
Acesso em linha:http://www.trialsjournal.com/content/12/1/120
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados